Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
1981-4-13
|
pubmed:language |
ita
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0017-0445
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
397-406
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:400151-Adult,
pubmed-meshheading:400151-Amikacin,
pubmed-meshheading:400151-Bacterial Infections,
pubmed-meshheading:400151-Escherichia coli,
pubmed-meshheading:400151-Humans,
pubmed-meshheading:400151-Infant, Newborn,
pubmed-meshheading:400151-Kanamycin,
pubmed-meshheading:400151-Proteus,
pubmed-meshheading:400151-Pseudomonas
|
pubmed:articleTitle |
[The role of amikacin in conditions requiring chemotherapy with aminoglycoside antibiotics].
|
pubmed:publicationType |
Journal Article
|